to assess the effects of mitochondrial DNA (mtDNA) haplogroups on SARS-CoV-2 sensitivity

Grant number: INV-046722

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2022
  • Known Financial Commitments (USD)

    $2,324,617
  • Funder

    Gates Foundation
  • Research Location

    United States of America
  • Lead Research Institution

    Children's Hospital of Philadelphia
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management
  • Research Subcategory

    Disease pathogenesis
  • Special Interest Tags

    N/A
  • Study Type

    Unspecified
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Unspecified
  • Vulnerable Population

    Unspecified
  • Occupations of Interest

    Unspecified

Abstract

N/A

6 Publications linked via Europe PMC

Mitochondrial OXPHOS restricts SARS-CoV-2 replication.

Importance of De Novo Gene Evolution to Emerging Viral Threats: The ORF10 Strain-Restricted Orphan Gene of SARS-CoV-2 Promotes Pathogenesis.

Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes.

PET Imaging with [18F]ROStrace Detects Oxidative Stress and Predicts Parkinson's Disease Progression in Mice.

Mitochondrial antioxidants abate SARS-COV-2 pathology in mice.

SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19.